Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. (Q53539779)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. |
scientific article |
Statements
Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy. (English)
Koichi Azuma
Yoshihiro Komohara
Tetsuro Sasada
Yasuhiro Terazaki
Jiro Ikeda
Tomoaki Hoshino
Kyogo Itoh
Akira Yamada
Hisamichi Aizawa
19 July 2007
98
9
1336-1343